deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT04992845

Fusionless Treatment of Idiopathic Scoliosis With the SCOLI-TETHER System During The Growth Period (FUTURE)

Sponsor: Spino Modulation Inc.

Updated 6 times since 2021 Last updated: Mar 12, 2024 Started: Apr 15, 2019 Primary completion: Sep 1, 2023 Completion: Sep 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The Sponsor decided to focus their resources on the clinical data collection for the second generation of the investigational device.

Listed as NCT04992845, this NA trial focuses on Adolescent Idiopathic Scoliosis and Juvenile Idiopathic Scoliosis and remains terminated or withdrawn. Sponsored by Spino Modulation Inc., it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshotRecruiting~Mar 2022 – ~May 2023 · 14 months · monthly snapshotActive Not Recruiting~May 2023 – ~Apr 2024 · 11 months · monthly snapshotActive Not Recruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Apr 2024 — Jul 2024 [monthly]

    Terminated NA

    Status: Active Not RecruitingTerminated

  4. May 2023 — Apr 2024 [monthly]

    Active Not Recruiting NA

  5. Mar 2022 — May 2023 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

Show 1 earlier version
  1. Sep 2021 — Mar 2022 [monthly]

    Recruiting NA

    First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Spino Modulation Inc.
Data source: Spinologics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations